← The Wire
SLDBNasdaq
Solid Biosciences Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1707502
Advancing gene therapy candidates for genetic cardiac and neuromuscular diseases
red 8-K · 90d
$703M
Market cap
$9.47
Last close
+1.9%
1D
+14.1%
5D
1.8M
Volume
Price · last 39 sessions+31.0%
May 4L $6.08 · H $9.47Jun 29
150
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
SC 13D/ASC 13D/AJun 24, 20268-KShareholder VoteJun 10, 202610-Q10-QMay 12, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KExecutive ChangeApr 10, 202610-K10-KMar 19, 2026SC 13D/ASC 13D/AMar 17, 20268-KReg FD Disclosure · Company UpdateMar 12, 2026SC 13D/ASC 13D/AMar 11, 2026SC 13D/ASC 13D/AMar 10, 2026SC 13D/ASC 13D/AMar 10, 20268-KMaterial Agreement · Results of OperationsMar 6, 202610-Q10-QNov 3, 20258-KResults of Operations · Reg FD DisclosureNov 3, 202510-Q10-QAug 12, 20258-KExecutive Change · Shareholder VoteJun 13, 20258-KCompany UpdateMay 15, 2025424B5424B5May 15, 202510-Q10-QMay 15, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 202510-K10-KMar 6, 20258-KMaterial Agreement · Company UpdateFeb 18, 2025424B5424B5Feb 18, 20258-KCompany UpdateFeb 18, 20258-KResults of Operations · Company UpdateFeb 18, 2025SC 13GSOLID BIOSCIENCES INC.Nov 14, 202410-Q10-QNov 6, 202410-Q10-QAug 13, 20248-KExecutive Change · Shareholder VoteJun 11, 2024SC 13GSC 13GJun 5, 202410-Q10-QMay 15, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 202410-K10-KMar 13, 2024SC 13GSOLID BIOSCIENCES INC.Feb 7, 2024SC 13GSC 13GJan 22, 2024SC 13GSC 13GJan 12, 20248-KMaterial Agreement · Results of OperationsJan 8, 20248-KReg FD Disclosure · Company UpdateNov 15, 202310-Q10-QNov 8, 202310-Q10-QAug 14, 20238-KExecutive Change · Shareholder VoteJun 9, 20238-KExecutive ChangeMay 22, 202310-Q10-QMay 11, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 2023424B5424B5Mar 23, 202310-K10-KMar 23, 20238-KReg FD DisclosureMar 20, 20238-KReg FD DisclosureMar 13, 20238-KExecutive Change · Results of OperationsJan 9, 2023SC 13GPRIMARY DOCUMENTDec 12, 20228-KExecutive Change · Material AgreementDec 5, 20228-KExecutive Change · Shareholder VoteDec 1, 202210-Q10-QNov 10, 20228-KSecurity-Holder Rights · Bylaw AmendmentOct 27, 2022DEFA14ADEFA14ASep 30, 20228-KReg FD DisclosureSep 30, 2022DEFA14ADEFA14ASep 30, 20228-KExecutive Change · Material AgreementSep 30, 2022SC 13GSC 13GSep 1, 20228-KResults of OperationsAug 11, 202210-Q10-QAug 11, 2022SC 13GSC 13GJul 8, 20228-KShareholder VoteJun 9, 20228-KDelisting NoticeJun 6, 2022DEFA14ADEFA14AApr 28, 2022DEF 14ADEF 14AApr 28, 20228-KExecutive Change · Results of OperationsApr 27, 202210-Q10-QApr 27, 20228-KCode of EthicsApr 4, 202210-K10-KMar 14, 2022SC 13GSC 13GFeb 4, 20228-KResults of Operations · Company UpdateJan 10, 202210-Q10-QNov 3, 20218-KCompany UpdateSep 29, 20218-K/ACompany UpdateSep 27, 20218-KCompany UpdateSep 23, 2021
Insider Activity
In the 90 days to Feb 18, 2026: 7 sold $2.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Cumbo AlexanderPresident and CEO | Sell | 16,644 | $5.82 | $97K |
| Feb 18, 2026 | Howton David TChief Operating Officer | Sell | 7,469 | $5.82 | $43K |
| Feb 18, 2026 | Tan KevinCFO & Treasurer | Sell | 5,404 | $5.82 | $31K |
| Feb 18, 2026 | Hanrahan JessieChief Regulatory Officer | Sell | 4,134 | $5.82 | $24K |
| Feb 18, 2026 | Herzich PaulChief Technology Officer | Sell | 3,616 | $5.82 | $21K |
| Feb 18, 2026 | Ganot IlanDirector | Sell | 2,658 | $5.82 | $15K |
| Feb 18, 2026 | Brooks GabrielChief Medical Officer | Sell | 0 | $5.82 | $0 |
| Feb 4, 2026 | Cumbo AlexanderPresident and CEO | Sell | 48,913 | $6.44 | $315K |
| Feb 4, 2026 | Howton David TChief Operating Officer | Sell | 18,894 | $6.44 | $122K |
| Feb 4, 2026 | Tan KevinCFO & Treasurer | Sell | 14,783 | $6.44 | $95K |
| Feb 4, 2026 | Brooks GabrielChief Medical Officer | Sell | 12,616 | $6.44 | $81K |
| Feb 4, 2026 | Hanrahan JessieChief Regulatory Officer | Sell | 12,348 | $6.44 | $80K |
| Feb 4, 2026 | Herzich PaulChief Technology Officer | Sell | 10,905 | $6.44 | $70K |
| Feb 4, 2026 | Ganot IlanDirector | Sell | 7,205 | $6.44 | $46K |
| Feb 2, 2026 | Cumbo AlexanderPresident and CEO | Sell | 80,258 | $6.44 | $517K |
| Feb 2, 2026 | Howton David TChief Operating Officer | Sell | 37,771 | $6.44 | $243K |
| Feb 2, 2026 | Brooks GabrielChief Medical Officer | Sell | 28,335 | $6.44 | $182K |
| Feb 2, 2026 | Tan KevinCFO & Treasurer | Sell | 26,837 | $6.44 | $173K |
| Feb 2, 2026 | Hanrahan JessieChief Regulatory Officer | Sell | 26,535 | $6.44 | $171K |
| Feb 2, 2026 | Herzich PaulChief Technology Officer | Sell | 26,250 | $6.44 | $169K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance